본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Natural product sciences v.16 no.2, 2010년, pp.59 - 67  
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Recent Advances in Anti-inflammatory Synthetic Flavonoids as Potential Drugs

Kim, Hyun-Pyo    (College of Pharmacy, Kangwon National University   ); Park, Hae-Il    (College of Pharmacy, Kangwon National University  );
  • 초록

    Flavonoids are well-known anti-inflammatory agents that exert their effects via a variety of mechanisms including antioxidative action, inhibition of eicosanoid metabolizing enzymes and regulation of theexpression of proinflammatory molecules. In this review, synthetic approaches to obtain more useful flavonoid derivatives are summarized. Human clinical trials of flavonoid therapy are discussed. Through continual investigation to identify more potent and comparable flavonoids, new anti-inflammatory flavonoid therapy will be successfully launched, especially for the treatment of chronic inflammatory disorders.


  • 주제어

    Synthetic flavonoid .   Anti-inflammation .   Clinical trial.  

  • 참고문헌 (56)

    1. Beck, G., Bergmann, K., Kebeler, K., and Wess, G., Synthesis of a new flavonoid-antioxidant. Tetrahedron Lett., 31, 7293-7296 (1990).?? 
    2. Boots, A.W., Wilms, L.C., Swennen, E.L.R., Kleinjans, J.C.S., Bast, A., and Haenen, G.R.M.M., In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutr., 24, 703-710 (2008). 
    3. Chen, X., Cui, L., Duan, X., Ma, B., and Zhong, D., Pharmacokinetics and metabolism of two flavonoid scutellarin in humans after a single oral administration. Drug Metab. Dispos., 34, 1345-1352 (2006). 
    4. Cho, H., Yun, C.-W., Park, W.-K., Kong, J.-Y., Kim, K.S., Park, Y., Lee, S., and Kim, B.-K., Modulation of the activity of proinflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharm. Res., 49, 37-43 (2004). 
    5. Chung, M.-I., Han, F.-W., Lin, H.-C., Liou, S.-S., Huang, P.-L., Ko, H.-H., Chang, Y.-L., Kang, J.-J., Teng, C.-M., and Lin, C.-N., Synthesis, antiplatelet and vasorelaxing effects of monooxygenated flavones and flavonoxypropanolamines. J. Pharm. Pharmacol., 53, 1601-1609 (2001). 
    6. Conquer, J.A., Maiani, G., Azzini, E., Raguzzini, A., and Holub, B.J., Supplementation with quercetin markedly increase plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr., 128, 593-597 (1998). 
    7. Conti, C., Desideri, N., Orsi, N., Sestili, I., and Stein, M.L., Synthesis and antirhinovirus activity of cyano and amidino substituted flavanoids. Eur. J. Chem., 25, 725-730 (1990). 
    8. Cunningham, B.D.M., Threadgill, M.D., Grounwater, P.W., Dale, I.L., and Hickman, J.A., Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases. Anti- Cancer Drug Design, 7, 365-384 (1992). 
    9. Dao, T.T., Chi, Y.S., Kim, J., Kim, H.P., Kim, S.H., and Park, H., Synthesis and PGE2 inhibitory activity of 5,7-dihydroxyflavones and their O-methylated flavone analogs. Arch. Pharm. Res., 26, 345-350 (2003a).     
    10. Dao, T.T., Chi, Y.S., Kim, J., Kim, H.P., Kim, S., and Park, H., Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives. Bioorg. Med. Chem. Lett., 14, 1165-1167 (2004). 
    11. de Pascual-Teresa, S., Johnston, K.L., DuPont, M.S., O'Leary, K.A., Needs, P.W., Morgan, L.M., Clifford, M.N., Bao, Y., and Williamson, G., Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J. Nutr., 134, 552-557 (2004). 
    12. Edwards, R.L., Lyon, T., Litwin, S.E., Rabousky, A., Symons, J.D., and Jalili, T., Quercetin reduces blood pressure in hypertensive subjects. J. Nutr., 137, 2405-2411 (2007). 
    13. Egert, S., Bosy-Westphal, A., Seiberi, J., Kurbitz, C., Settler, U., Plachta- Danielzik, S., Wagner, A.E., Frank, J., Schrezenmeir, J., Rimbach, G., Wolffran, S., and Muller, M.J., Quercetin reduces systolic blood pressure and plasma oxidized low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br. J. Nutr., 102, 1065-1074 (2009). 
    14. Ertan, R., Goker, H., Ertan, M., Beretz, A., Cazenave, J.P., Haag, M., and Anton, R., Synthesis of some flavone derivatives: potent inhibitors of human platelet aggregation. Chimie, 26, 735-738 (1991). 
    15. Ferry, D.R., Smith, A., Malkhandi, J., Fyfe, D.W., de Takats, P.G., Anderson, D., Baker, J., and Kerr, D.J., Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clinical Cancer Research, 2, 659-668 (1996). 
    16. Filipe, P., Silva, A.M.S., Seixas, R.S.G.R., Pinto, D.C.G.A., Santos, A., Patterson, L.K., Silva, J.N., Cavaleir, J.A.S., Freitas, J.P., Maziere, J.- C., Santus, R., and Morliere, P., The alkyl chain length of 3-alkyl- 3',4',5,7-tetrahydroxyflavones modulates effective inhibition of oxidative damage in biological systems: Illustration with LDL, red blood cells and human keratinocytes. Biochem. Pharmacol., 77, 957- 964 (2009). 
    17. Gabor, M., Anti-inflammatory and anti-allergic properties of flavonoids, In Cody et al. (eds.), Plant flavonoids in biology and medicine: Biochemical, pharmacological, and structure-activity relationships, Alan R. Liss, New York, 1986, pp. 471-480. 
    18. Gao, H. and Kawabata, J.,$alpha$-Glucosidase inhibition of 6-hydroxyflavones. Part 3: Synthesis and evaluation of 2,3,4-trihydroxybenzoylcontaining flavonoid analogs and 6-aminoflavones as $alpha$-glucosidase inhibitors. Bioorg. Med. Chem., 13, 1661-1671 (2005). 
    19. Gugler, R., Leschik, M., and Dengler, H.J., Disposition of quercetin in man after single oral and intraveneous doses. Eur. J. Clin. Pharmacol., 9, 229-234 (1975). 
    20. Han, C.K., Son, M.J., Chang, H.W., Chi, Y.S., Par, H., and Kim, H.P., Inhibition of prostaglandin production by a structurally-optimized flavonoid derivative, 2',4',7-trimethoxyflavone and cellular action mechanism. Biol. Pharm. Bull., 28, 1366-1370 (2005). 
    21. Havsteen, B., Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol., 32, 1141-1148 (1983). 
    22. Herencia, F., Ferrandiz, M.L., Ubeda, A., Gwillen, I., Dominguez, J.N., Charris, J.E., Lobo, G.M., and Alcaraz, M.J., Novel anti-inflammatory chalcone derivatives inhibit the induction of nitric oxide synthase and cyclooxygenase-2 in mouse peritoneal macrophages. FEBS Lett., 453, 129-134 (1999). 
    23. Hirano, T., Oka, K., Kawashima, E., and Akiba, M., Effects of synthetic and naturally occurring flavonoids on mitogen-induced proliferation of human peripheral-blood lymphocytes. Life Sci., 45, 1407-1441 (1989). 
    24. Horie, T., Tsukayama, M., Kourai, H., Yokoyama, C., Furukawa, M., Yoshimoto, T., Yamamoto, S., Waranabe-Kohno, S., and Ohata, K., Synthesis of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase. J. Med. Chem., 29, 2256-2262 (1986). 
    25. Huang, W.-H., Lee, A.-R., Chien, P.-Y., and Chou, T.-Z., Synthesis of baicalein derivatives as potential antiaggregatory and antiinflammatory agents. J. Pharm. Pharmacol., 57, 219-225 (2005). 
    26. Jang, J., Kim, H.P., and Park, H., Structure and anti-inflammatory activity relationships of wogonin derivatives. Arch. Pharm. Res., 28, 877-884 (2005).     
    27. Joo, A.H., Kim, J.K., Kang, S.-H., Noh, M.-S., Ha, J.-Y., Choi, J.K., Lim, K.M., Lee, C.H., and Chung, S., 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. Lett., 13, 413-417 (2003). 
    28. Kim, H.P., Son, K.H., Chang, H.W., and Kang, S.S., Anti-inflammatory flavonoids and cellular action mechanisms. J Pharmacol. Sci., 96, 229-245 (2004a). 
    29. Kim, S.J., Park, H., and Kim, H.P., Inhibition of nitric oxide production from lipopolysaccharide-treated RAW264.7 cells by synthetic flavones: Structure-activity relationship and action mechanism. Arch. Pharm. Res., 27, 937-943 (2004b).     
    30. Kim, Y.H., Kim, J., Park, H., and Kim, H.P., Anti-inflammatory activity of the synthetic chalcone derivatives: Inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharidetreated RAW 264.7 cells. Biol. Pharm. Bull., 30, 1450-1455 (2007). 
    31. Knekt, P., Kumpulainen, J., Jarvinen, R., Rissanen, H., Heliovaara, M., Reunanen, A., Hakulinen, T., and Aromaa, A., Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr., 76, 560-568 (2002). 
    32. Kometani, T., Fukuda, T., Kakuma, T., Kawaguchi, K., Tamura, W., Kumazawa, Y., and Nagata, K., Effects of $\alpha$-glucosylhesperidin, a bioactive food material, on collagen-induced arthritis in mice and rheumatoid arthritis in humans. Immunopharmacol. Immunotoxicol., 30, 117-134 (2008). 
    33. Lebeau, J., Furman, C., Bernier, J.-U., Duriez, P., Teissier, E., and Cotelle, N., Antioxidant properties of di-tert-butylhydroxylated flavonoids. Free Rad. Biol. Med., 29, 900-912 (2000). 
    34. Lee, S.J., Baek, H.J., Lee, C.H., and Kim, H.P., Anti-inflammatory activity of isoflavonoids from Pueraria radix and biochanin A derivatives. Arch. Pharm. Res., 17, 31-35 (1994). 
    35. Levy, R.M., Saikovsky, R., Shmidt, E., Khokhlov, A., and Burnett, B.P., Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study. Nutr. Res., 29, 298-304 (2009). 
    36. Liao, H.-L. and Hu, M.-K., Synthesis and anticancer activities of 5,6,7- trimethylbaicalein derivatives. Chem. Pharm. Bull., 52, 462-465 (2004). 
    37. Lin, C.-N., Lee, T.-H., Hsu, M.-F., Wang, J.-P., Ko, F.-N., and Teng, C.- M., 2'.5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. J. Pharm. Pharmacol., 49, 530-536 (1997). 
    38. Liu, T., Xu, Z., He, Q., Chen, Y., Yang, B., and Hu, Y., Nitrogencontaining flavonoids as CDK1/cyclin B inhibitors: Design, synthesis, and biological evaluation. Bioorg. Med. Chem. Lett., 17, 278-281 (2007). 
    39. Loke, W.M., Hodgson, J.M., Proudfoot, J.M., McKinly, A.J., Puddey, I.B., and Croft, K.D., Pure dietary flavonoids quercetin and (-)- epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr., 88, 1018-1025 (2008). 
    40. Losiewicz, M.D., Carlson, B.A., Kaur, G., Sausville, E.A., and Worland, P.J., Potent inhibition of CDC2 kinase activity by the flavonoid L86- 8275. Biochem. Biophys. Res. Comm., 201, 589-595 (1994). 
    41. McAnulty, S.R., McAnulty, L.S., Nieman, D.C., Quindry, J.C., Hosick, P.A., Hudson, M.H., Still, L., Henson, D.A., Milne, G.L., Morrow, J.D., Dumke, C.L., Utter, A.C., Triplett, N.T., and Dibarnardi, A., Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation. Appl. Physiol. Nutr. Metab., 33, 254-262 (2008). 
    42. Middleton, E., Kandaswami, C., and Theoharides, T.C., The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 52, 673-751 (2000). 
    43. Moon, Y.J., Wang, L., DiCenzo, R., and Morris, M.E., Quercetin pharmacokinetics in humans. Biopharm. Drug. Dispos., 29, 205-217 (2008). 
    44. Nagai, T., Miyaichi, Y., Tomimori, T., and Yamada, H., Inhibition of mouse liver sialidase by plant flavonoids. Biochem. Biophys. Res. Comm., 163, 25-31 (1989). 
    45. Park, H., Dao, T.T., and Kim, H.P., Synthesis and inhibition of PGE2 production of 6,8-disubstituted chrysin derivatives. Eur. J. Med. Chem., 40, 943-948 (2005). 
    46. Quintin, J., Buisson, D., Thoret, S., Cresteil, T., and Lewin, G., Semisynthesis and antiproliferative evaluation of a series of 3'- aminoflavones. Bioorg. Med. Chem. Lett., 19, 3502-3506 (2009). 
    47. Ullmann, U., Metzner, J., Frank, T., Cohn, W., and Riegger, C., Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers. Adv. Ther., 22, 65-78 (2005). 
    48. Vasquez-Martinez, Y., Ohri, R.V., Kenyon, V., Holman, T.R., and Sepulveda-Boza, S., Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15hLO-1, and prostate epithelial 15hLO-2. Bioorg. Med. Chem., 15, 7408-7425 (2007). 
    49. Viola, H., Marder, M., Wasowski, C., Giorgi, O., Paladini, A.C., and Medina, J.H., 6,3'-Dibromoflavone and 6-nitro-3'-bromoflavone: New additions to the 6,3'-disubstituted flavone family of high-affinity ligands of the brain benzodiazepine binding site with agonistic properties. Biochem. Biophys. Res. Comm., 273, 694-698 (2000). 
    50. Wu, E.S.C., Cole, T.E., Davidson, T.A., Blosser, J.C., Borrelli, A.R., Kingsolving, C.R., and Parker, R.B., Flavones. I. Synthesis and antihypertensive activity of 3-phenylflavone-oxopropanolamines without $\beta$-adrenergic receptor antagonism. J. Med. Chem., 30, 788-792 (1987). 
    51. Wu, E.S.C., Loch, J.T., Toder, B.H., Borrelli, A.R., Gawlak, D., Radov, L.A., and Gensmantel, N.P., Flavones. 3. Synthesis, biological activities, and conformational analysis of isoflavone derivatives and related compounds. J. Med. Chem., 35, 3519-3525 (1992). 
    52. Yahiaoui, S., Fagnere, C., Pouget, C., Buxeraud, J., and Chulia, A.-J., New 7,8-benzoflavanones as potent aromatase inhibitors: Synthesis and biological evaluation. Bioorg. Med. Chem., 16, 1474-1480 (2008). 
    53. Yamada, H., Tateishi, M., Harada, K., Ohashi, T., Shimizu, T., Atsumi, T., Komagata, Y., Iijima, H., Komiyama, K., Watanabe, H., Hara, Y., and Ohashi, K., A randomized clinical study of tea catechin inhalation effects on methicillin-resistant Staphylococcus aureus in disabled elderly patients. J. Am. Med. Dir. Assoc., 7, 79-83 (2006). 
    54. Yarishkin, O.V., Ryu, H.W., Park, J.-Y., Yang, M.S., Hong, S.-G., and Park, K.H., Sulfonate chalcone as new class voltage-dependent $K^{+}$ channel blocker. Bioorg. Med. Chem. Lett., 18, 137-140 (2008). 
    55. Dao, T.T., Oh, J.W., Chi, Y.S., Kim, H.P., Sin, K.-S., and Park, H., Synthesis and PGE2 inhibitory activity of vinylated and allylated chrysin analogues. Arch. Pharm. Res., 26, 581-584 (2003b).     
    56. Gunnarsson, G.T., Riaz, M., Adams, J., and Desai, U.R., Synthesis of persulfated flavonoids using 2,2,2-trichloroethyl protecting group and their factor Xa inhibition potential. Bioorg. Med. Chem., 13, 1783- 1789 (2005). 

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • NDSL :
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기